197 related articles for article (PubMed ID: 23046238)
41. Rapid and complete donor chimerism after unrelated mismatched cord blood transplantation in 5 children with beta-thalassemia major.
Jaing TH; Hung IJ; Yang CP; Chen SH; Sun CF; Chow R
Biol Blood Marrow Transplant; 2005 May; 11(5):349-53. PubMed ID: 15846288
[TBL] [Abstract][Full Text] [Related]
42. Donor leukocyte infusions after unrelated donor hematopoietic stem cell transplantation.
Loren AW; Porter DL
Curr Opin Oncol; 2006 Mar; 18(2):107-14. PubMed ID: 16462177
[TBL] [Abstract][Full Text] [Related]
43. Dose-reduced conditioning and allogeneic hematopoietic stem cell transplantation from unrelated donors in 42 patients.
Bornhäuser M; Thiede C; Platzbecker U; Jenke A; Helwig A; Plettig R; Freiberg-Richter J; Röllig C; Geissler G; Lutterbeck K; Oelschlagel U; Ehninger G
Clin Cancer Res; 2001 Aug; 7(8):2254-62. PubMed ID: 11489799
[TBL] [Abstract][Full Text] [Related]
44. [Allogeneic hematopoietic stem cell transplantation in patients with chronic myeloid leukemia in the Czech Republic--a retrospective analysis of results in years 1988-2005].
Faber E; Koza V; Vítek A; Mayer J; Sedlácek P; Zák P; Zapletalová J; Benesová K; Krejcová H; Steinerová K; Maresová I; Cetkovský P
Vnitr Lek; 2006 Dec; 52(12):1172-80. PubMed ID: 17299910
[TBL] [Abstract][Full Text] [Related]
45. Peripheral blood stem cell transplantation in children with beta-thalassemia major.
Farzana T; Shamshi TS; Irfan M; Ansari SH; Baig MI; Shakoor N
J Coll Physicians Surg Pak; 2003 Apr; 13(4):204-6. PubMed ID: 12718774
[TBL] [Abstract][Full Text] [Related]
46. [Therapeuetic management of patients with thalassemia major].
Thuret I
Bull Soc Pathol Exot; 2001 May; 94(2):95-7. PubMed ID: 11475036
[TBL] [Abstract][Full Text] [Related]
47. The impact of hematopoietic stem cell transplantation on the management of thalassemia.
Isgrò A; Marziali M; Sodani P; Gaziev J; Lucarelli G
Expert Rev Hematol; 2009 Jun; 2(3):335-44. PubMed ID: 21082973
[TBL] [Abstract][Full Text] [Related]
48. Audit of peripheral stem cell transplantation for aplastic anemia in multitransfused infected patients.
Seth T; Kanga U; Sood P; Sharma V; Mishra P; Mahapatra M
Transplant Proc; 2012 May; 44(4):922-4. PubMed ID: 22564586
[TBL] [Abstract][Full Text] [Related]
49. Hematopoietic stem cell allografts using a non-myeloablative conditioning regimen can be safely performed on an outpatient basis: report of four cases.
Gómez-Almaguer D; Ruiz-Argüelles GJ; Ruiz-Argüelles A; González-Llano O; Cantú OE; Hernández NE
Bone Marrow Transplant; 2000 Jan; 25(2):131-3. PubMed ID: 10673669
[TBL] [Abstract][Full Text] [Related]
50. Pre-transplant cytomegalovirus (CMV) serostatus remains the most important determinant of CMV reactivation after allogeneic hematopoietic stem cell transplantation in the era of surveillance and preemptive therapy.
George B; Pati N; Gilroy N; Ratnamohan M; Huang G; Kerridge I; Hertzberg M; Gottlieb D; Bradstock K
Transpl Infect Dis; 2010 Aug; 12(4):322-9. PubMed ID: 20487414
[TBL] [Abstract][Full Text] [Related]
51. Pure red-cell aplasia following major and bi-directional ABO-incompatible allogeneic stem-cell transplantation: recovery of donor-derived erythropoiesis after long-term treatment using different therapeutic strategies.
Helbig G; Stella-Holowiecka B; Wojnar J; Krawczyk M; Krzemien S; Wojciechowska-Sadus M; Markiewicz M; Wylezol I; Kopera M; Holowiecki J
Ann Hematol; 2007 Sep; 86(9):677-83. PubMed ID: 17486341
[TBL] [Abstract][Full Text] [Related]
52. [Hematopoietic stem cell transplantation for beta-thalassemia major].
Zhu W; Yang M; He Y
Zhonghua Yi Xue Za Zhi; 2000 Apr; 80(4):265-7. PubMed ID: 11798768
[TBL] [Abstract][Full Text] [Related]
53. Cytokine-mobilized allogeneic peripheral blood stem cell transplants in children result in rapid engraftment and a high incidence of chronic GVHD.
Levine JE; Wiley J; Kletzel M; Yanik G; Hutchinson RJ; Koehler M; Neudorf S
Bone Marrow Transplant; 2000 Jan; 25(1):13-8. PubMed ID: 10654008
[TBL] [Abstract][Full Text] [Related]
54. Hematopoietic stem cell transplantation for thalassemia.
Gaziev J; Lucarelli G
Curr Stem Cell Res Ther; 2011 Jun; 6(2):162-9. PubMed ID: 21190532
[TBL] [Abstract][Full Text] [Related]
55. Beyond transfusion therapy: new therapies in thalassemia including drugs, alternate donor transplant, and gene therapy.
Porter J
Hematology Am Soc Hematol Educ Program; 2018 Nov; 2018(1):361-370. PubMed ID: 30504333
[TBL] [Abstract][Full Text] [Related]
56. Ethical issues of unrelated hematopoietic stem cell transplantation in adult thalassemia patients.
Caocci G; La Nasa G; d'Aloja E; Vacca A; Piras E; Pintor M; Demontis R; Pisu S
BMC Med Ethics; 2011 Mar; 12():4. PubMed ID: 21385429
[TBL] [Abstract][Full Text] [Related]
57. Impact of splenectomy on outcomes of hematopoietic stem cell transplantation in pediatric patients with transfusion-dependent thalassemia.
Sanpakit K; Narkbunnam N; Buaboonnam J; Takpradit C; Viprakasit V; Pongtanakul B
Pediatr Blood Cancer; 2020 Sep; 67(9):e28483. PubMed ID: 32568454
[TBL] [Abstract][Full Text] [Related]
58. Marrow transplantation for patients with thalassemia: results in class 3 patients.
Lucarelli G; Clift RA; Galimberti M; Polchi P; Angelucci E; Baronciani D; Giardini C; Andreani M; Manna M; Nesci S; Agostinelli F; Rapa S; Ripalti M; Albertini F
Blood; 1996 Mar; 87(5):2082-8. PubMed ID: 8634461
[TBL] [Abstract][Full Text] [Related]
59. Hematopoietic stem cell transplantation in thalassemia.
Angelucci E
Hematology Am Soc Hematol Educ Program; 2010; 2010():456-62. PubMed ID: 21239835
[TBL] [Abstract][Full Text] [Related]
60. Hurdles to the Adoption of Gene Therapy as a Curative Option for Transfusion-Dependent Thalassemia.
Thuret I; Ruggeri A; Angelucci E; Chabannon C
Stem Cells Transl Med; 2022 Apr; 11(4):407-414. PubMed ID: 35267028
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
